Cargando…

Thymosin β4 Protects against Cardiac Damage and Subsequent Cardiac Fibrosis in Mice with Myocardial Infarction

BACKGROUND: Inflammation is a critical factor in the development and progression of myocardial infarction and cardiac fibrosis. Thymosin β4 (Tβ4) alleviates the disease process via protective antioxidant and anti-inflammatory mechanisms. Although Tβ4 has been shown to have a protective effect in myo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fei, He, Yajuan, Yao, Naijuan, Ruan, Litao, Tian, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187458/ https://www.ncbi.nlm.nih.gov/pubmed/35712678 http://dx.doi.org/10.1155/2022/1308651

Ejemplares similares

High levels of serum superoxide dismutase as a biomarker of intrahepatic cholestasis of pregnancy in patients with viral hepatitis B
por: Wang, Fei, et al.
Publicado: (2022)

Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue
por: Kumar, Arun, et al.
Publicado: (2014)

Senescent Cardiac Fibroblast Is Critical for Cardiac Fibrosis after Myocardial Infarction
por: Zhu, Fuli, et al.
Publicado: (2013)

Protective effects of Salidroside on cardiac function in mice with myocardial infarction
por: Chen, Pengsheng, et al.
Publicado: (2019)

Diabetes influences cardiac extracellular matrix remodelling after myocardial infarction and subsequent development of cardiac dysfunction
por: Eguchi, Megumi, et al.
Publicado: (2012)

Effects of Thymosin β4 on Myocardial Apoptosis in Burned Rats
por: Wu, Xiaoming, et al.
Publicado: (2022)

Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration
por: Talman, Virpi, et al.
Publicado: (2016)

Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
por: Raziyeva, Kamila, et al.
Publicado: (2022)

Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis
por: Amrute, Junedh M., et al.
Publicado: (2023)

Synthesis and Characterization of Injectable Hydrogels with Varying Collagen–Chitosan–Thymosin β4 Composition for Myocardial Infarction Therapy
por: Shaghiera, Achmad Dzihan, et al.
Publicado: (2018)

MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats
por: Wang, Guoyu, et al.
Publicado: (2020)

Thymosin β4-sulfoxide attenuates inflammatory cell infiltration and promotes cardiac wound healing
por: Evans, Mark A., et al.
Publicado: (2013)

Thymosin β4 and prothymosin α promote cardiac regeneration post-ischaemic injury in mice
por: Gladka, Monika M, et al.
Publicado: (2022)

Glycolysis Inhibition Alleviates Cardiac Fibrosis After Myocardial Infarction by Suppressing Cardiac Fibroblast Activation
por: Chen, Zhi-Teng, et al.
Publicado: (2021)

Aldehyde dehydrogenase-2 protects against myocardial infarction-related cardiac fibrosis through modulation of the Wnt/β-catenin signaling pathway
por: Zhao, Xinjun, et al.
Publicado: (2015)

MicroRNA-24 regulates cardiac fibrosis after myocardial infarction
por: Wang, Jue, et al.
Publicado: (2012)

Corosolic acid attenuates cardiac fibrosis following myocardial infarction in mice
por: Wang, Zhao-Peng, et al.
Publicado: (2020)

Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium
por: Quan, Zhe, et al.
Publicado: (2017)

Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparative potency of human induced-pluripotent stem cell-derived cardiomyocytes in a porcine model of acute myocardial infarction
por: Tan, Shi Hua, et al.
Publicado: (2021)

Cellular Therapy for Repair of Cardiac Damage after Acute Myocardial Infarction
por: Cook, Matthew M., et al.
Publicado: (2009)

Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro
por: Xiao, Jie, et al.
Publicado: (2016)

miR-30a attenuates cardiac fibrosis in rats with myocardial infarction by inhibiting CTGF
por: Chen, Liwen, et al.
Publicado: (2018)

Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin β-4 in the Dystrophin Deficient Mouse
por: Spurney, Christopher F., et al.
Publicado: (2010)

Effects of exogenous thymosin β4 on carbon tetrachloride-induced liver injury and fibrosis
por: Li, Xiankui, et al.
Publicado: (2017)

Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis
por: Aimo, Alberto, et al.
Publicado: (2022)

Curcumin Protects Against Myocardial Infarction-Induced Cardiac Fibrosis via SIRT1 Activation in vivo and in vitro [Corrigendum]
Publicado: (2022)

Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]
por: Idrus, Hasta Handayani, et al.
Publicado: (2023)

Potential Role of Thymosin Beta 4 in Liver Fibrosis
por: Kim, Jieun, et al.
Publicado: (2015)

Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure
por: Yao, Naijuan, et al.
Publicado: (2022)

Protection effect of thymosin β4 on ethanol injury in corneal stromal keratocyte
por: Liu, Jinghua, et al.
Publicado: (2022)

Cardiac troponin and defining myocardial infarction
por: Kaier, Thomas E, et al.
Publicado: (2021)

Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction
por: Liu, Zhaoya, et al.
Publicado: (2019)

Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction
por: Ni, Tingjuan, et al.
Publicado: (2021)

Cardiac Remodeling After Myocardial Infarction: Functional Contribution of microRNAs to Inflammation and Fibrosis
por: Varzideh, Fahimeh, et al.
Publicado: (2022)

Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice
por: Gil, Hadas, et al.
Publicado: (2022)

Downregulation of microRNA-218 is cardioprotective against cardiac fibrosis and cardiac function impairment in myocardial infarction by binding to MITF
por: Qian, Linfeng, et al.
Publicado: (2019)

Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction
por: Sui, Xizhong, et al.
Publicado: (2015)

Inhibition of TGF-β1 by eNOS gene transfer provides cardiac protection after myocardial infarction
por: Qin, Wei, et al.
Publicado: (2010)

Protective effects of Xinji′erkang on myocardial infarction induced cardiac injury in mice
por: Hu, Juan, et al.
Publicado: (2017)

Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_la0p87nni5r7oo9u6rqf6a44vo